The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species.
We have studied the effects of the extracellular molecular chaperone, clusterin, on the in vitro aggregation of mutational variants of human lysozyme, including one associated with familial amyloid disease. The aggregation of the amyloidogenic variant I56T is inhibited significantly at clusterin to...
Main Authors: | Kumita, JR, Poon, S, Caddy, G, Hagan, C, Dumoulin, M, Yerbury, J, Stewart, E, Robinson, C, Wilson, MR, Dobson, C |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2007
|
פריטים דומים
-
Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme.
מאת: Johnson, R, et al.
יצא לאור: (2005) -
The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
מאת: Patricia Yuste-Checa, et al.
יצא לאור: (2021-08-01) -
The significance of the location of mutations for the native-state dynamics of human lysozyme
מאת: Ahn, M, et al.
יצא לאור: (2016) -
The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI)
מאת: Abigail K. Elias, et al.
יצא לאור: (2022-10-01) -
Expression and purification of chaperone-active recombinant clusterin.
מאת: Rebecca A Dabbs, et al.
יצא לאור: (2014-01-01)